These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 15458360)

  • 1. [Effect of metabolic substances of oral Actinomyces on Candida albicans].
    Gutiérrez de Annan S; Benito de Cárdenas L
    Rev Iberoam Micol; 2004 Mar; 21(1):29-34. PubMed ID: 15458360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effects of oral Actinomyces on the proliferation, virulence and biofilm formation of Candida albicans.
    Guo Y; Wei C; Liu C; Li D; Sun J; Huang H; Zhou H
    Arch Oral Biol; 2015 Sep; 60(9):1368-74. PubMed ID: 26143096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Study the inhibitory effects of three oral actinomyces on growth of oral Candida albicans in vitro].
    Li D; Xiao XR; Zhu Z; Ren Q; Hu T; Gong QM; Zhou HM
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2008 Oct; 26(5):553-5. PubMed ID: 19007084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymicrobial biofilm formation by Candida albicans, Actinomyces naeslundii, and Streptococcus mutans is Candida albicans strain and medium dependent.
    Arzmi MH; Alnuaimi AD; Dashper S; Cirillo N; Reynolds EC; McCullough M
    Med Mycol; 2016 Nov; 54(8):856-64. PubMed ID: 27354487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial activity of varying concentrations of sodium hypochlorite on the endodontic microorganisms Actinomyces israelii, A. naeslundii, Candida albicans and Enterococcus faecalis.
    Radcliffe CE; Potouridou L; Qureshi R; Habahbeh N; Qualtrough A; Worthington H; Drucker DB
    Int Endod J; 2004 Jul; 37(7):438-46. PubMed ID: 15189432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coaggregation of Candida albicans, Actinomyces naeslundii and Streptococcus mutans is Candida albicans strain dependent.
    Arzmi MH; Dashper S; Catmull D; Cirillo N; Reynolds EC; McCullough M
    FEMS Yeast Res; 2015 Aug; 15(5):fov038. PubMed ID: 26054855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Voriconazole inhibits cross-kingdom interactions between Candida albicans and Actinomyces viscosus through the ergosterol pathway.
    Deng L; Zou L; Wu J; Liu H; Luo T; Zhou X; Li W; Ren B
    Int J Antimicrob Agents; 2019 Jun; 53(6):805-813. PubMed ID: 30818001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methicillin-resistant Staphylococcus aureus and Candida albicans on denture surfaces.
    Tawara Y; Honma K; Naito Y
    Bull Tokyo Dent Coll; 1996 Aug; 37(3):119-28. PubMed ID: 9151568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of saliva or serum on bacterial and Candida albicans colonization on type I collagen.
    Nikawa H; Egusa H; Yamashiro H; Nishimura M; Makihira S; Jin C; Fukushima H; Hamada T
    J Oral Rehabil; 2006 Oct; 33(10):767-74. PubMed ID: 16938106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment and distribution of Actinomyces viscosus and Actinomyces naeslundii in the human oral cavity.
    Ellen RP
    Infect Immun; 1976 Nov; 14(5):1119-24. PubMed ID: 977124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycogen synthetic abilities of Actinomyces viscosus and Actinomyces naeslundii freshly isolated from dental plaque over root surface caries lesions and non-carious sites.
    Komiyama K; Khandelwal RL; Duncan DE
    J Dent Res; 1986 Jun; 65(6):899-902. PubMed ID: 3458740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacterial inhibition produced by substances for dentin pretreatment.
    Molgatini S; Abate PF; Negroni MB; Macchi RL; González MI
    Acta Odontol Latinoam; 1993; 7(2):3-11. PubMed ID: 11885245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in the adsorptive behavior of human strains of Actinomyces viscosus and Actinomyces naeslundii to saliva-treated hydroxyapatite surfaces.
    Qureshi JV; Gibbons RJ
    Infect Immun; 1981 Jan; 31(1):261-6. PubMed ID: 7216448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Actinomyces viscosus and Actinomyces naeslundii agglutinins in human saliva.
    Ellen RP; Bratthall D; Borgström M; Howley TP
    Scand J Dent Res; 1983 Aug; 91(4):263-73. PubMed ID: 6579605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution of antigenic determinants between Actinomyces viscosus and Actinomyces naeslundii.
    Firtel M; Fillery ED
    J Dent Res; 1988 Jan; 67(1):15-20. PubMed ID: 11039037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential medium for detecting dental plaque bacteria resembling Actinomyces viscosus and Actinomyces naeslundii.
    Ellen RP; Balcerzak-Raczkowski IB
    J Clin Microbiol; 1975 Oct; 2(4):305-10. PubMed ID: 1184734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and characterization of anti-microbial effects produced by Actinomyces viscosus and Actinomyces naeslundii.
    Tompkins GR; Tagg JR
    J Dent Res; 1986 Feb; 65(2):109-12. PubMed ID: 3455964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycogen synthetic and degradative activities by Actinomyces viscosus and Actinomyces naeslundii of root surface caries and noncaries sites.
    Komiyama K; Khandelwal RL; Heinrich SE
    Caries Res; 1988; 22(4):217-25. PubMed ID: 3165713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of Actin-omyces israelii, A. naeslundii, Bacterionema matruchotii, and Candida albicans in selected areas of the oral cavity and saliva.
    HOWELL A; STEPHAN RM; PAUL F
    J Dent Res; 1962; 41():1050-9. PubMed ID: 13955156
    [No Abstract]   [Full Text] [Related]  

  • 20. New medium for isolation of Actinomyces viscosus and Actinomyces naeslundii from dental plaque.
    Kornman KS; Loesche WJ
    J Clin Microbiol; 1978 Jun; 7(6):514-8. PubMed ID: 670376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.